Västra Frölunda, Sweden

Ann-Mari Svennerholm

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Vastra Frolunda, SE (2000)
  • Västra Frölunda, SE (2016 - 2024)

Company Filing History:


Years Active: 2000-2024

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Celebrating the Innovations of Ann-Mari Svennerholm

Introduction

Ann-Mari Svennerholm, an accomplished inventor based in Västra Frölunda, Sweden, has made significant contributions to the field of immunology and vaccine development. With eight patents to her name, her work focuses primarily on creating effective vaccines against ETEC-induced diarrhea, a major health issue worldwide.

Latest Patents

Among her notable patents, Svennerholm has developed a groundbreaking vaccine for protection against ETEC-induced diarrhea. This oral vaccine comprises inactivated cells expressing an ETEC colonization factor antigen and utilizes dmLT protein adjuvant, optimizing the dosage to less than 10 cells per unit. Additionally, she has patented a method for increasing the ETEC CS6 antigen presentation on cell surfaces. This method involves treating cells with an aqueous solution containing 0.6-2.2 percent phenol by weight, resulting in a significant improvement in antigen presentation by at least 100%. Furthermore, her work includes a method for manufacturing a killed whole cell vaccine aimed at immunization against CS6-expressing ETEC, showcasing her dedication to advancing vaccine technology.

Career Highlights

Ann-Mari Svennerholm has had a remarkable career marked by her innovative research in vaccine development. Her dedication to the field has placed her as a key figure in the fight against infectious diseases, particularly those caused by ETEC.

Collaborations

Throughout her career, Svennerholm has collaborated with esteemed professionals such as Nils Carlin and Joshua Tobias. These collaborations have contributed to her successful research and development efforts, allowing her to leverage combined expertise for innovative solutions in vaccine technology.

Conclusion

Ann-Mari Svennerholm continues to be a prominent figure in immunology, with her patents reflecting her deep commitment to improving global health. Her innovative approaches to vaccine development are not only significant to scientific advancement but also crucial for public health initiatives combating ETEC-induced diseases. Through her work, she stands as an inspiration to aspiring inventors and researchers worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…